Answer
Inclisiran sodium uses RNA interference in liver cells to break down PCSK9 messenger RNA, increasing LDL receptor recycling and expression on liver cell surfaces, which increases LDL cholesterol uptake and lowers circulating LDL cholesterol.
Sources for this answer
- Leqvio 284 mg solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked